Who We Help
Expanding Access to Safer Imaging
Designed for the Patients Who Need It Most
GADZero Ultra represents a new era of MRI safety—bringing proven chemistry and breakthrough stability to patients who rely on diagnostic imaging the most. By significantly reducing free gadolinium exposure, Inventure enables safer, more accessible contrast-enhanced MRIs for those once limited by safety concerns.
01.
Chronic Kidney Disease
For individuals with impaired kidney function, traditional contrast agents require extreme caution due to the risk of gadolinium retention and NSF.
GADZero Ultra’s ultra-stable molecular structure minimizes free gadolinium release, creating a safer pathway for essential diagnostic imaging. This innovation helps physicians obtain clear, contrast-enhanced MRI results without compromising patient safety—expanding access to care for millions living with chronic conditions.
02.
Patients Requiring Multiple MRI Scans
Patients in oncology, neurology, and chronic care often require repeated MRI scans for monitoring and treatment planning.
With GADZero Ultra, clinicians can perform up to fourteen contrast-enhanced MRIs with the same cumulative exposure as a single traditional scan. This breakthrough allows consistent, reliable imaging over time—supporting early intervention and precise tracking of disease progression.
03.
Cancer Screening
Contrast-enhanced MRI remains one of the most powerful tools for early tumor detection and ongoing cancer surveillance.
GADZero Ultra enhances this capability by combining high-definition image quality with a dramatically improved safety margin. From annual breast MRIs to full-body oncology scans, our ultra-stable agents enable clearer, safer imaging—helping clinicians detect disease earlier and monitor outcomes more effectively.
